MORGAN STANLEY

Position in BNTC — Benitec Biopharma Inc.

CIK 895421 NEW YORK, NY

Position in BNTC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$311,725

-$480,472 QoQ

Shares Held

29,270

-50.2% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. BNTC ranks #307 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$311,725	29,270	-50.2%	Shares	Defined	2026-05-15
2025-12-31	$792,197	58,812	+264.9%	Shares	Defined	2026-05-27
2025-09-30	$226,121	16,117	-53.0%	Shares	Defined	2026-05-27
2025-06-30	$401,566	34,322	+28.7%	Shares	Defined	2025-08-15
2025-03-31	$346,845	26,660	-37.1%	Shares	Defined	2025-05-15
2024-12-31	$535,095	42,367	+3099.9%	Shares	Defined	2025-05-15
2024-09-30	$12,167	1,324	-76.4%	Shares	Defined	2025-05-14
2024-06-30	$39,144	5,600	-52.5%	Shares	Defined	2025-05-14
2024-03-31	$61,950	11,800	+131.4%	Shares	Defined	2024-10-17
2023-12-31	$16,473	5,100	—	Shares	Defined	2024-08-16
No filing history on record for this holder in this stock.